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A D2 Class Dopamine Receptor Transactivates
a Receptor Tyrosine Kinase to Inhibit
NMDA Receptor Transmission
and Schuman, 1995; Man et al., 2000). However, the
circumstances under which RTKs modulate synaptic
performance and the mechanisms involved remain
poorly understood.
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carinic and metabotropic glutamate receptors, modu-2 Department of Pharmacology
late NMDAR-mediated synaptic transmission (Lu et al.,3 Department of Psychiatry
1999; Harvey et al., 1993). In addition, GPCRs can indi-4 Department of Anesthesiology
rectly activate the mitogen-activated protein kinase5 Institute of Medical Science
(MAPK) signal cascade in heterologous cells by trans-6 Centre for Addiction and Mental Health
activating RTKs such as the EGFR and PDGFR (Gutkind,Faculty of Medicine
1998; Luttrell et al., 1999; Oak et al., 2001). The termUniversity of Toronto
transactivation refers to the process whereby GPCRsToronto, Ontario
stimulate autophosphorylation and activation of RTKsCanada
with a subsequent signaling to intracellular pathways
such as the MAPK cascade. Transactivation has been
reported for a number of GPCRs (dopamine, muscarinic,
angiotensin, thrombin) and may occur via intracellularSummary
signaling pathways (Daub et al., 1996) or by activating
transmembrane metalloproteinases which subsequentlyReceptor tyrosine kinases (RTKs) are membrane span-
induce the release of a ligand that interacts with thening proteins with intrinsic kinase activity. Although
ectodomain of an RTK (Prenzel et al., 1999). Whetherthese receptors are known to be involved in prolifera-
such receptor interaction occurs in neurons and whattion and differentiation of cells, their roles in regulating
effect RTK transactivation has on synaptic transmissioncentral synaptic transmission are largely unknown. In
has never been determined.CA1 pyramidal neurons, activation of D2 class dopa-
Dopamine, a major transmitter and neuromodulatormine receptors depressed excitatory transmission
in the CNS, is implicated in several psychiatric disordersmediated by the NMDA subtype of glutamate receptor.
including schizophrenia, attention deficit hyperactivityThis depression resulted from the quinpirole-induced
disorder, and Tourette’s Syndrome (Barkley et al., 1998;release of intracellular Ca2 and enhanced Ca2-
Lewis and Lieberman, 2000; Swanson et al., 1998; Todddependent inactivation of NMDA receptors. The dopa-
and O’Malley, 2001; Weickert et al., 2000; Weinberger,mine receptor-mediated depression was dependent
1999). Dopamine receptors have been classified intoon the “transactivation” of PDGFR. Therefore, RTK
two categories, D1-like (D1, D5 receptors) and D2-liketransactivation provides a novel mechanism of com-
(D2, D3, D4), based upon sequence homology, signalmunication between dopaminergic and glutamatergic
transduction mechanisms, and agonist affinity. Thissystems and might help to explain how reciprocal
transmitter mediates its signaling through GPCRs ofchanges in these systems could be linked to the defi-
which the D2 class of dopamine receptors is the targetcits in cognition, memory, and attention observed in
for most common antipsychotics (for review, see See-schizophrenia and attention deficit hyperactivity dis-
man and Van Tol, 1994). Several cortical and limbicorder.
structures, and specifically the hippocampus, have been
implicated in the deficits of cognition, memory, and at-
Introduction
tention associated with schizophrenia and attention def-
icit hyperactivity disorder (Barkley, 1998; Lewis and
Receptor tyrosine kinases (RTKs) are highly and ubiqui- Lieberman, 2000; Swanson et al., 1998; Todd and O’Mal-
tously expressed in the central nervous system and their ley, 2001; Weickert et al., 2000; Weinberger, 1999).
activity modulates the developing, mature, and diseased Behavioral evidence suggests that the D2 class of re-
brain. One of these RTKs, platelet-derived growth factor ceptors plays an important role in attention and/or cog-
(PDGF), exerts neurotrophic effects on GABAergic and nition, likely through modulation of the signaling medi-
dopaminergic neurons (Valenzuela et al., 1996) and has ated by the NMDA subtype of postsynaptic glutamate
long-lasting modulatory effects on N-methyl-D-aspar- receptor (Arnsten et al., 2000; Jentsch and Roth, 1999;
tate (NMDAR) receptor-mediated synaptic transmission Todd and O’Malley, 2001).
in the hippocampus (Lei et al., 1999; Valenzuela et al., Long-term potentiation (LTP) at CA1 synapses in the
1996). Epidermal growth factor receptors (EGFRs) and hippocampus provides a model of learning and memory
brain-derived nerve factor receptors (BDNFRs) are also (Bliss and Collingridge, 1993). NMDARs are nonselective
expressed in hippocampal tissue, but in contrast to cation channels that are substantially permeable to Ca2
PDGFRs and insulin receptors, their activation has been (McBain and Mayer, 1994), and the influx of Ca2 through
reported to cause a long-lasting enhancement of excit- these channels is required to induce CA1-LTP (Malenka
atory synaptic transmission (Abe and Saito, 1992; Kang and Nicoll, 1999). Paradoxically, the same Ca2 influx
that is required to induce LTP also acts via the Ca2-
dependent regulatory protein calmodulin to inactivate7 Correspondence: j.macdonald@utoronto.ca
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these channels, a process referred to as Ca2-depen- of activating a D2 receptor-mediated intracellular signal-
ing cascade. We chose to employ quinpirole to triggerdent inactivation. Calcium inactivation of NMDARs re-
this signaling pathway in all subsequent experiments.sults in part from the displacement of the actin binding
The use of dopamine was abandoned because of itsprotein -actinin-2 from a binding site on the NR1 sub-
direct inhibitory effects on NMDA channels and becauseunit (Krupp et al., 1999).
it lacks selectivity for D2 class receptors.The CA1 region is innervated by dopaminergic fibers
To further confirm that quinpirole was signaling via(Descarries et al., 1987; Gasbarri et al., 1994) and it
activation of D2 receptors, we made coapplications ofexpresses immunocytochemically localized D2 and D4
quinpirole together with spiperone (10 M), a broadreceptors, but not D3 receptors (Meador-Woodruff et
spectrum D2 antagonist. This antagonist blocked theal., 1994; Oak et al., 2000). Applications of dopamine
depression (Figure 1F). We next investigated which ofinhibit NMDAR-mediated transmission at CA1 neurons
the D2 class receptor subtypes (D2, D3, or D4) mediates(Otmakhova and Lisman, 1999), suggesting that dopa-
this response. The depression was blocked by the selec-mine might depress LTP by inhibiting NMDAR function.
tive D4 antagonist, L-745,780 (10 M), but not by 10 MWe report here that D2/D4 receptors in CA1 neurons
raclopride; at this concentration, raclopride is a D2/D3inhibit NMDAR currents and synaptic transmission via
selective antagonist. At 100M, raclopride D4 receptorsthe transactivation of PDGFRs. The D2/D4-PDGFR sig-
are inhibited (Seeman and Van Tol, 1993), and we foundnal cascade acts subsequently to enhance calmodulin-
that 100 M raclopride also antagonized the quinpiroleand Ca2-dependent inactivation of NMDARs (Rosen-
response (Figure 1F). Collectively, these results stronglymund and Westbrook, 1993; Zhang et al., 1998) and
suggest that activation of D4 receptors is required, butthereby inhibit excitatory synaptic transmission.
they do not exclude the possibility of D2 class receptor
heterogeneity.Results
Considering that not all GPCR signaling is mediated
via G proteins (Hall et al., 1999), we initially confirmedApplications of dopamine to cultured hippocampal neu-
that the quinpirole-induced depression of NMDA-evokedrons caused a rapid, readily reversible concentration-
currents required G protein activity. We included(Figure 1A1) and voltage-dependent (Figure 1A2) block
GDPS, a persistent G protein inhibitor, in the patchof NMDA-evoked currents that is consistent with the
recording electrode solution and found that it blockedopen channel block of these channels by many amines
the quinpirole response without changing the amplitude(Lu et al., 1998; Castro et al., 1999). This direct block was
of NMDA-mediated currents itself (Figure 2A). The spe-observed in cultured neurons even though responses to
cific G subunit involved is likely Gi/o, as including pertus-a specific D2 agonist, quinpirole (see following), were
sis toxin (PTx) (Uchida et al., 2000) in the patch pipetteabsent (data not shown). These results illustrate the
blocked the response to quinpirole (Figure 2A). The G-potential of misinterpreting a direct effect of exogenous
sequestering peptide, ARK(CT)-GST (Inglese et al.,dopamine on NMDARs for a cell signaling event medi-
1994), also prevented the depression. As a control, weated by dopamine receptors. In contrast, quinpirole (10
showed that ARK(CT)-GST itself did not modulate
M), a selective agonist of the D2 class of receptors,
NMDA-evoked currents, and inclusion of GST protein in
did not directly depress NMDA-induced responses in
the recording electrode failed to inhibit the quinpirole-
cultured neurons (Figure 1B).
induced depression (Figure 2A). Collectively, these re-
Applications of quinpirole (Figures 1D, 1E1, and 1E2) sults confirm the involvement of G proteins in mediating
or low concentrations of dopamine (10 M) (Figure 1C) the D2/D4-induced response. D2 class dopamine recep-
to acutely isolated CA1 pyramidal neurons, but not cul- tors are positively coupled to Gi/o subunits and are knowntured hippocampal neurons, evoked a long-lasting de- to inhibit adenylyl cyclase activity. Consistent with these
pression of peak NMDAR currents that far outlasted the reports, we found that the quinpirole-induced depres-
duration of their application. No currents were evoked by sion of NMDAR currents was dependent upon Gi/o sub-
applications of quinpirole itself. The quinpirole-induced units (Figure 2A). However, the quinpirole-induced de-
depression did not reverse over the first 25 min of re- pression was unaffected by the presence of either of
cording in whole-cell recordings (Figures 1E1 and E2). two potent PKA inhibitors (Rp-cAMPs or PKI) (Figure
However, when NMDAR currents were recorded using 2B) in the patch pipettes, suggesting that the response
the perforated-patch configuration, we were able to is unlikely to be mediated via the inhibition of PKA.
demonstrate a reversal of the inhibition following pro- PDGFB causes a similar depression of NMDA-evoked
longed washing (Figure 1D). The quinpirole effect in currents in CA1 neurons (Lei et al., 1999; Valenzuela et
whole-cell recordings was concentration dependent, al., 1996) (Figure 3A), and various GPCRs transactivate
with a maximal inhibition of peak currents observed using the PDGFR (Luttrell et al., 1999). Indeed, in heterologous
10 M quinpirole (Figure 1E1). Steady-state NMDAR cur- cell lines, activation of D2 or D4 dopamine receptors
rents were also depressed in a concentration-depen- activates MAPK via signaling mechanisms that require
dent manner (Figure 1E2). All subsequent figures illus- PDGFR activity (Oak et al., 2001). In light of these ob-
trate the effects of quinpirole on peak NMDAR currents servations, we hypothesized that the quinpirole-induced
as steady-state currents were similarly depressed. The inhibition of NMDAR currents might therefore be medi-
amplitude of NMDA-mediated currents in isolated neu- ated via transactivation of the PDGFR. We found that
rons remained constant over the same time course (note applications of PDGFB occluded the depression in-
Figure 1D with subthreshold concentration of quinpir- duced by quinpirole (Figure 3A), suggesting that D2/
ole). The most parsimonious explanation for the long- D4 receptors share similar signaling mechanisms as
PDGFRs. To inhibit the activity of PDGFRs, we includedlasting depression is that it represents the consequence
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Figure 1. D2/D4 Dopamine Receptors Depress NMDA-Evoked Currents in CA1 Pyramidal Neurons
(A1) Applications of dopamine caused a direct, concentration-dependent inhibition of NMDAR currents in primary cultured hippocampal
neurons. (A2) This direct block by 1000 M dopamine was voltage dependent (currents traces are normalized to the peak; inhibition at 90
mV: 85.4% 7%, inhibition at30 mV: 32.9% 9%, n 4, p	 0.001). (B) The direct block of NMDA responses was not seen with applications
of quinpirole (10 M). Applications of extracellular solution (ECF) served as control for this perfusion. (C) Applications of dopamine (10 M)
to acutely isolated CA1 pyramidal neurons evoked a long-lasting depression of NMDAR currents that far outlasted the period of application.
(D) A similar depression of NMDAR currents was observed using the perforated patch recording configuration. Under these conditions, the
quinpirole effect reversed after prolonged wash (peak, control: 99%  2%; quinpirole: 70%  6%; wash: 92%  8%, n  5, p 	 0.001; steady-
state, control: 99.2%  2%; quinpirole: 69%  6%; wash: 87%  8%, n  5, p 	 0.001). (E1 and E2) In whole-cell recordings from isolated
neurons, the quinpirole-induced depression occurred in a concentration-dependent manner. (E1) At 1 M (77%  8%, n  9, p 	 0.001) and
10 M (69%  3.7%, n  9, p 	 0.001), quinpirole depressed peak NMDAR currents, 100 nM quinpirole (101.5%  3.5%, n  8) was
subthreshold for this effect. (E2) Steady-state currents were depressed in response to 1 M (73%  6%, n  9, p 	 0.001) and 10 M (61% 
4%, n  9, p 	 0.001), but not 100 nM quinpirole (90%  4.1%, n  8). The black solid bar indicates when quinpirole was applied. (F)
Quinpirole’s effect on NMDAR currents is mediated via D2-like receptors. Coapplication of 10 M spiperone blocked the quinpirole effect
(quinpirole: 68%  3.7%, n  5; quinpirole  spiperone: 90%  3.4%, n  7, p 	 0.001, all data taken at 20 min). Applications of spiperone
itself did not modulate NMDA-evoked currents (97%  3.5%, n  6). L-745,870 (10 M) antagonized the quinpirole-induced depression
(quinpirole: 69%  6%, n  6; L-745,780: 96%  5%, n  6; quinpirole  L-745,780: 91%  7%, n  6, p 	 0.001) whereas 10 M raclopride
did not, but 100 M raclopride did (quinpirole: 70%  3%, n  5; raclopride: 96%  4%, n  6; quinpirole  10 M raclopride: 80%  1.5%,
n  5; quinpirole  100 M raclopride: 94%  5%, n  5, p 	 0.001). At a concentration of 100 M raclopride, both D2 and D4 receptors
are antagonized. All data taken at 20 min.
in the patch electrodes one or the other of the PDGFR mediated via protein kinase C (PKC), the tyrosine kinase
cell adhesion protein kinase  (CAK or Pyk2), and thetyrosine kinase inhibitors, Win41662 (Lei et al., 1999;
Sawutz et al., 1996) or tyrphostin A9 (T-A9) (Herrlich et nonreceptor tyrosine kinase, c-Src (Huang et al., 2001).
PDGFB induces receptor autophosphorylation, signalal., 1998). Both prevented the PDGFB-induced depres-
sion of NMDAR currents (Figure 3B2) and similarly activation, and subsequent PDGFR internalization (Hel-
din et al., 1998). Both autophosphorylation and internal-blocked the quinpirole-induced depression of these cur-
rents (Figures 3B1 and 3B2). By themselves, Win41662 ization can be used as measures of transactivation. We,
therefore, transiently expressed the D4.2 dopamine re-and T-A9 failed to modulate NMDA-evoked responses
(Figure 3B1). The functional selectivity of these com- ceptor in HEK293 cells overexpressing PDGFR. Appli-
cations of dopamine (10 M) induced tyrosine phos-pounds was confirmed by their failure to block the phor-
bol ester (4-PMA)-induced enhancement of NMDA- phorylation of PDGFRs (Figure 3D), as did applications
of 10 ng/ml PDGFB. In order to indirectly confirmevoked currents (Lu et al., 1999) (Figure 3B2) that is
Neuron
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Figure 2. D2/D4 Depression of NMDAR Currents Is Dependent on G Protein Activity but Not PKA
(A) Application of GDPS blocked the D2/D4 effect (quinpirole: 70%  5%, n  7; GDPS  quinpirole: 89%  5%, n  6, p 	 0.001). GDPS
by itself did not modulate NMDAR currents (20 M, 91%  5%, n  6). The Gi/o inhibitor pertussis toxin (PTx, 5 g/ml) inhibited the D2/D4-
induced depression when included in the patch electrode (quinpirole: 73%  2.7%, n  6; PTx: 95%  5%, n  5; quinpirole  PTx: 100% 
2%, n  5, p 	 0.001). With the G-scavenging peptide ARK(CT) (5 M) in the internal recording solution, quinpirole no longer depressed
NMDAR currents (quinpirole: 71%  5%, n  6; quinpirole  ARK(CT): 105%  3%, n  7, p 	 0.001). ARK(CT) by itself did not modulate
NMDAR currents (99%  5%, n  4) and the GST protein (5 M) failed to alter the degree of inhibition (78%  6%, n  6, data taken at 20
min). Applications of PDGF also depressed NMDA-evoked currents yet this effect was not blocked by ARK(CT) (PDGF: 74.6%  6%, n  6;
PDGF  ARK(CT): 77.5%  7%, n  4). (B) Intracellular applications of PKI and Rp-cAMPS did not modulate NMDAR currents and failed
to prevent the quinpirole-induced depression of these currents (quinpirole: 69%  8%, n  5, p 	 0.001; PKI: 94%  6%, n  5; quinpirole 
PKI: 73%  9%, n  7, p 	 0.001; Rp-cAMPS: 96%  4%, n  4; quinpirole  Rp-cAMPS: 70%  8%, n  5). Bar graphs illustrate data
taken at 20 min, reported values represent maximal inhibition.
PDGFR transactivation in single isolated CA1 pyrami- We first investigated the role of PI3 kinase, but found
that a selective PI3 kinase inhibitor, wortmanin (10 M),dal neurons, we examined the effects of quinpirole on
immunocytochemically detected PDGFR internalization failed to prevent the quinpirole-induced depression (Fig-
ure 4A) as it had similarly failed to inhibit PDGFB-(Pierce et al., 2000). Applications of PDGFB rapidly stim-
ulated internalization of membrane PDGFRs, and this induced inhibition (Lei et al., 1999). In contrast, the PLC
inhibitor U73122, but not inactive U73343, blocked thiseffect was mimicked by quinpirole (Figure 3C). The effect
of quinpirole was attenuated by preapplications of response (Figure 4B) as well as the response to PDGFB
(Lei et al., 1999). This result is also consistent with ourL-745,780, demonstrating the involvement of D4 recep-
tors. In contrast, quinpirole failed to induce the internal- previous demonstration that depression of NMDA-
evoked currents requires autophosphorylation of tyro-ization of EGF receptors (Figure 3C).
Autophosphorylation of specific tyrosine residues on sine 1021 of the PDGFR and activation of PLC (Valen-
zuela et al., 1996). Phospholipase C can activate PKC,PDGFRs provides docking or adaptor sites that support
activation of a variety of signal pathways involving mole- as well as mobilize intracellular Ca2by means of inositol
triphosphate (IP3) receptors. However, the quinpirole-cules such as phospholipase C (PLC), PI3 kinase, and
Src (Claesson-Welsh, 1994). In isolated CA1 pyramidal induced depression was not sensitive to the PKC inhibi-
tor chelerythrine (quinpirole: 72%  4%, n  6; quinpi-and in cultured hippocampal neurons, activation of
PDGFRs depressed NMDAR activity via activation of role  chelerythrine: 80%  5%, n  5; chelerythrine:
88% 5%, n 6, data taken at 20 min, data not shown),PLC and increased intracellular Ca2, but did not depend
upon PI3K activation or upon the stimulation of cal- and, surprisingly, applications of 4-PMA (activator of
endogenous PKC) accentuated the inhibitory effect ofcineurin (Valenzuela et al., 1996). Furthermore, coex-
pression of recombinant PDGFR and NMDARs con- quinpirole (Figure 4C), perhaps by sensitizing Ca2-
dependent inactivation of NMDARs (Lu et al., 2000) (seefirmed these features of the signaling, and the use of
add-back mutations of the PDGFR tyrosine residues below). These results suggest that the quinpirole-
induced signal requires activation of PLC but not PKC.demonstrated the likely requirement for activation of
PLC. We therefore anticipated that quinpirole would In contrast, strong buffering of intracellular Ca2 (25
mM BAPTA) or the inclusion of the IP3R blocker, Xesto-similarly signal to NMDARs provided its actions were
mediated via PDGFR transactivation. However, as the spongin-C (Xe-C) (Gafni et al., 1997), in the patch pipette
blocked the quinpirole response (Figure 4D), implyingmechanism of growth factor receptor transactivation or
phosphorylation is still poorly understood, some of that quinpirole acting via PDGFR stimulated a rise in
intracellular Ca2, which in turn inactivated NMDARs.these signaling events may also be involved upstream
in the actual transactivation mechanism. Calmodulin contributes together with Ca2 to the inacti-
Dopamine Receptor Transactivation of NMDA Receptor
1115
Figure 3. D2/D4 Transactivates PDGFRs to Depress NMDA Channel Activity
(A) PDGF (5 ng/ml) depressed NMDAR currents. Subsequent application of quinpirole (10 M) did not further depress NMDAR currents (PDGF:
70%  7%, n  6; PDGF  quinpirole: 75%  6%, n  6). Current traces illustrate that PDGF depressed NMDAR currents and occluded
the quinpirole effect. (B1) Inclusion of Win41662, a PDGFR inhibitor, in the patch pipette prevented the quinpirole-induced depression of
NMDAR currents (quinpirole: 69%  4%, n  6; quinpirole  Win41662 (3 M): 94%  5%, n  5, p 	 0.001). Win41662 by itself did not
affect NMDA-evoked currents. Similar results were obtained with another PDGFR inhibitor tyrphostin A9 (quinpirole: 71%  5%, n  4; T-A9
(2 M)  quinpirole: 88%  3%, n  5, p 	 0.001; T-A9: 94%  5%, n  5). (B2) The PDGF-induced depression of NMDAR currents (PDGF:
74.7%  5%, n  6) was also blocked by Win41662 (PDGF  Win41662: 96.6%  7%, n  3) and TA9 (PDGF  TA9: 95.3%  6%, n  3).
TA9 did not, however, block the PMA (PKC/Pyk2/Src) induced enhancement of NMDAR currents (PMA: 143.5%  7%, n  6; PMA  TA9:
138.5%  5%, n  5). (C) Membrane PDGFRs were labeled with an anti-mouse PDGFR monoclonal antibody. In the absence of agonist,
PDGFRs were primarily localized to the cell membrane (i). When challenged by either 5 ng/ml PDGF (ii) or 10 M quinpirole (iii), these receptors
were internalized. L-745,780 reduced the quinpirole-induced internalization (iv), and quinpirole failed to induce the internalization of membrane-
labeled EGF receptors (v). In the absence of primary antibody, no fluorescence was observed (vi). (D) Application of dopamine (or quinpirole
not shown) or PDGFB to clonal cell lines overexpressing the PDGF receptor, but transiently transfected with the D4.2 dopamine receptor,
induced a rapid (1 min) tyrosine phosphorylation of the PDGFR. Higher tyrosine phosphorylation levels were observed in response to application
of PDGF. Total PDGF immunoreactivity is shown in the lower panels.
vation of NMDARs (Ehlers et al., 1996; Zhang et al., without effect on the quinpirole-induced depression.
These results suggest that Ca2-dependent inactivation1998), and calmodulin is highly expressed in these neu-
rons (Popov et al., 1988). We therefore investigated the could underlie the depression of NMDA-evoked currents
activated by D2/D4-PDGFR transactivation.potential role of calmodulin in the D2/D4/PDGFR-
induced depression of NMDA-evoked currents. Consis- The quinpirole-induced depression was also exam-
ined using various concentrations of extracellular Ca2tent with this interpretation, inclusion of calmodulin (100
nM) in the patch electrode (Lu et al., 2000) blocked to test if Ca2 sensitivity of NMDARs to inactivation had
been altered (Lu et al., 2000). However, quinpirole failedthe response to quinpirole (Figure 5A). Moreover, the
calmodulin binding peptide KY9 (Lu et al., 2000), but not to alter the relationship between extracellular Ca2
(0.2 mM, 1.2 mM, and 5 mM) and the degree of NMDARthe control peptide KY8, also blocked this response
(Figure 5B). In contrast, the calmodulin-dependent ki- Ca2-dependent inactivation (Figures 5C–5E). As Ca2-
dependent inactivation also depends upon the state ofnase (CaMKII) inhibitor, KN-93 (KN-93, 2 M  quinpi-
role: 68% 6%, n 6; KN-92, inactive control quinpi- polymerization of filamentous actin, we tested the ef-
fects of including either a stabilizing (phalloidin) or de-role: 72%  4%, n  7; all values taken after 20 min of
recording) and the calcineurin inhibitor cyclosporin A stabilizing agent (cytochalasin-D) of actin in the patch
pipettes. We found that phallodin blocked the quinpirole(cyclosporin A, 2 M: 96.4%  3%, n  3; cyclosporin
A  quinpirole: 74.7%  7.3%, n  4; quinpirole: response, even though phalloidin itself failed to modu-
late NMDAR currents. Applications of cytochalasin-D in72.1%  6%, n  3, all data taken at 20 min) were
Neuron
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Figure 4. D2/D4-PDGFR Depression of
NMDAR Currents Is Dependent upon Activa-
tion of PLC-IP3-Ca2 Signal Cascade
(A) The PI3K inhibitor wortmannin failed to
prevent the D2/D4-PDGFR depression of
NMDAR currents (quinpirole: 68%  4%,
n  6, p 	 0.001; quinpirole  wortmannin:
71%  5%, n  5; wortmannin: 93%  4%,
n  6). (B) The active PLC inhibitor U73122
(5 M, 90% 8%, n 7) prevented the quin-
pirole-induced depression of NMDAR cur-
rents. The inactive isoform U73343 did not (5
M, 68%  3%, n  6, p 	 0.001). (C) Perfu-
sion of phorbol 12-myristate 13-acetate or
4-PMA (100 nM) enhanced the quinpirole
effect (PMA: 107% 3%, n 5; quinpirole
PMA: 55% 6%, p	 0.01, n  7, data taken
at 10 min). Current traces illustrate that PMA
enhances the quinpirole-induced depression.
(D) Strong buffering of intracellular Ca2 pre-
vented the quinpirole-induced depression of
NMDA currents (quinpirole: 73%  4%, n 
6; BAPTA: 115%  4%, n  5; quinpirole 
BAPTA: 122%  5%, n  5, p	 0.001). Simi-
larly, the IP3R inhibitor Xe-C (2.5 M) pre-
vented the quinpirole-induced depression of
NMDAR currents (quinpirole: 75% 4%, n
4; quinpirole  Xe-C: 92%  5%, n  5, p 	
0.001). By itself, Xe-C failed to modulate
NMDAR currents (95%  3%, n  5). All data
taken at 20 min.
the recording electrode solution induced a rundown of centration dependent, not particularly potent, rapid in
onset and offset, and demonstrates a marked voltageNMDAR currents (time 0 min: 100%; time 25 min with
cytochalasin-D: 74.7%  4%, n  6) and occluded the dependence. These properties are consistent with an
open channel blocking mechanism (Lu et al., 1998;quinpirole response (time 0 min: 100%; time 25 min after
quinpirole application in the presence of cytochala- McBain and Mayer, 1994). Furthermore, the direct block
is demonstrable in cultured neurons lacking D2 classsin-D: 78.3%  5%, n  5).
We then asked if quinpirole induced a depression of dopamine receptors. In neurons of the prefrontal cortex,
dopamine has been reported to potentiate NMDAR-synaptic NMDARs in hippocampal slices. Pharmacolog-
ically isolated epscsNMDA were recorded in CA1 pyramidal mediated responses via D1 receptors at low concentra-
tions (	50 M) and depress such responses at highneurons during stimulation of Schaffer-collaterals. Quin-
pirole was applied to the bathing solution and its effects concentrations (
50 M), perhaps via D2 receptors
(Law-Tho et al., 1994; Zheng et al., 1999). The directon epscsNMDA assessed. Quinpirole caused an approxi-
mately 20% depression of these synaptic currents (Fig- block of the channels by dopamine further complicates
interpretation of these results. However, it is highly un-ure 6A), which is consistent with its effects on isolated
CA1 neurons where both extrasynaptic and synaptic likely that synaptically released dopamine would reach
such high concentrations in excitatory glutamatergicreceptors may have been stimulated. Furthermore, this
depression was sensitive to the PDGFR tyrosine kinase synapses. Indeed, the capacity of D2/D4 receptors to
transactivate PDGFRs provides a novel mechanisminhibitor, TA9, the PLC inhibitor, U73122 (Figure 6A), and
the IP3R antagonist, Xestospongin-C (88.6%  8.9%, whereby dopamine receptors located remotely from ex-
citatory synapses can provide a modulatory signal.n  6, not shown). To confirm that quinpirole transacti-
vated PDGFRs in these slices, we microdissected the Dopamine has been reported to modify excitatory
synaptic transmission via potentiation of AMPA recep-CA1 region and immunoprecipitated tyrosine phosphor-
ylated proteins before probing with a PDGFR antibody. tors (Umemiya and Raymond, 1997) and/or NMDARs
(Blank et al., 1997; Seamans et al., 2001) via D1 recep-We also assayed ERK activity and probed for the phos-
phorylated MAPK substrate, Elk-1. Quinpirole caused tors. This modulation requires activation of PKA. For
example, in striatal neurons, D1 receptors activate PKA,both a transient stimulation of PDGFR and subsequent
persistent increase in the kinase activity of ERK1/2 (Fig- which in turn phosphorylates DARPP-32, a potent inhibi-
tor of protein phosphatase-1, leading to an enhancedure 6B).
phosphorylation of the NR1 subunit of the NMDA recep-
tor (Snyder et al., 1998, but see Nicola et al., 2000).Discussion
Similarly, D1 class agonists enhance excitatory synaptic
transmission in the CA1 hippocampus (Hsu, 1996). InWe have shown that dopamine, like many other amines,
can directly block NMDAR currents. The block is con- contrast, we have shown that D2/D4 receptors inhibit
Dopamine Receptor Transactivation of NMDA Receptor
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Figure 5. D2/D4-PDGFR Depresses NMDA-Mediated Currents by Enhancing Ca2-Dependent Inactivation
(A) Inclusion of calmodulin (100 nM) in the patch pipette blocked the quinpirole-induced depression of NMDAR currents (quinpirole: 69% 
5%, n  6; quinpirole  calmodulin: 95%  6%, n  7; calmodulin: 90%  4%, n  6). (B) The calmodulin binding peptide (KY9, 1 M,
108%  4%, n  8), but not its inactive isoform (KY8, 1 M, 68%  5%, n  9, p 	 0.001), blocked the quinpirole effect. (C and D) Quinpirole
depressed the peak and steady-state NMDA-mediated current response, and the degree of inhibition was similar at each extracellular Ca2
concentration. (E) The slope of the Iss/Ip to extracellular Ca2 concentration relationship was not significantly changed in response to quinpirole
application (control, open circles; slope  0.04; quinpirole treated, closed circles; slope  0.03).
NMDAR activity in the hippocampus by a mechanism depression of NMDAR currents, confirming that G sub-
units are upstream of PDGFR transactivation but down-that involves transactivation of PDGFRs and the subse-
quent enhancement of Ca2-dependent inactivation. stream of the D2/D4 dopamine receptor. Both applica-
tions of quinpirole and PDGFB depress NMDAR activityOur results are consistent with immunocytochemical
data demonstrating that the D2 dopamine class is ex- through mechanisms that depend upon stimulation of
PLC and an increase in intracellular calcium. PDGFBpressed in these neurons (Defagot et al., 2000) and with
extracellular recordings showing that dopamine D2 re- specifically inhibits NMDAR via activation of PLC but
does not require PI3K activation or stimulation of theceptor family antagonists block the dopamine-induced
depression of CA1 excitatory postsynaptic potentials phosphatase calcineurin (Valenzeula et al., 1996).
PDGFR transactivation may also require activation of(Otmakhova and Lisman, 1999). These finding may ac-
count for the observations that D1, but not D2, receptors PLC and the release of Ca2. For example, in isolated
striatal medium spinal neurons, quinpirole inhibited Lare essential for LTP in the hippocampal formation (Gur-
den et al., 2000; Huang and Kandel, 1995) while D2 class type Ca2 currents through activation of PLC, the sub-
sequent IP3-dependent release of Ca2, and poten-receptors facilitate LTD in the prefrontal cortex (Otani
et al., 1998; Calabresi et al., 1997). tial dephosphorylation of the channels by calcineurin
(Hernandez-Lopez et al., 2000). However, it was alsoStimulation of D2/D4 receptors in CA1 neurons de-
pressed NMDAR activity and excitatory NMDAR-medi- recently reported that a metabotropic glutamate recep-
tor (mGluR5), independent of its ability to activate PLC,ated synaptic transmission via the transactivation of
PDGFRs. This inhibition of NMDAR activity was associ- transactivates EGFR in astrocytes (Peavy et al., 2001). In
contrast to the effects of quinpirole on Ca2 channels, theated with phosphorylation of PDGFR, internalization of
PDGFR, as well as with activation of MAPK pathway depression of NMDARs was dependent upon calmodulin/
Ca2 and an intact actin cytoskeleton, suggesting an en-in the CA1 region of the hippocampus. The inhibition
evoked by quinpirole was also blocked by inhibitors hancement of Ca2 inactivation of NMDARs.
GPCRs can signal, via transactivation of growth factorof PDGFR tyrosine phosphorylation, providing further
evidence that D2/D4 receptors act via PDGFR transacti- receptors and the mitogen-activated protein kinase cas-
cade (MAPK), to alter gene transcription (Della et al.,vation. The transactivation was pertussis toxin sensitive
and blocked by administration of ARK(CT). Interest- 1999; Gutkind, 1998; Luttrell et al., 1999). However,
transactivation has not previously been implicated iningly, ARK(CT) failed to block the PDGF-induced
Neuron
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Figure 6. Quinpirole Depresses Synaptic
NMDARs via Transactivation of PDGFRs in
the CA1 Region of the Hippocampus
(A) Pharmacologically isolated epscsNMDA
were recorded from CA1 pyramidal neurons.
Applications of quinpirole (10 M for 10 min)
depressed these synaptic currents relative to
control recordings (75.9%  4.3%, n  11)
and this inhibition was prevented when the
PDGFR inhibitor tyrphostin-9 (2 M, 95.4%
3.4%, n 5) or when the PLC inhibitor U73122
(5 M, 92.2%  5.7%, n  6) was included
in the patch pipette. Differences between in-
tracellularly applied drug treatments and con-
trol recordings were significant (p 	 0.001)
as tested by one-way ANOVA analysis and
Dunnett’s multiple comparison post test. (B)
Applications of quinpirole for the durations
indicated by the bars evoked a persistent
phosphorylation of Elk-1 without altering the
amount of immunodetectable ERK1/2. (C) A
transient increase in tyrosine phosphorylated
PDGFR was observed during applications
of quinpirole.
the acute regulation of synaptic transmission. PDGFRs and stimulation of the MAPK pathway in the CA1 region
of the hippocampus. In individual CA1 pyramidal neu-are widely distributed on neurons of the cortex and hip-
pocampus but their function in the adult CNS is also rons, quinpirole also triggered receptor internalization.
All of this evidence provides strong support that the D2/poorly understood (Valenzuela et al., 1997). Activation
of these receptors alters both excitatory NMDA and in- D4 receptor subclass can transactivate PDGFRs in the
CA1 pyramidal neurons of the hippocampus. Transacti-hibitory GABAA receptors in hippocampal neurons, sug-
gesting that they play a role in modulating synaptic vation of PDGFRs, and the consequential inactivation
of NMDAR and the depression of epscsNMDA followingtransmission (Valenzuela et al., 1997).
We have shown that the D2/D4 receptor subtype stim- the release of Ca2 from intracellular stores, constitutes
a novel mechanism for intercommunication betweenulates autophosphorylation of PDGFRs in a clonal cell
line expressing the D4.2 receptor. In addition, applica- two major transmitter systems. Our results show that
PDGFRs are likely to play a pivotal role in synaptic neuro-tions of quinpirole induced phosphorylation of PDGFRs
Figure 7. Schematic Representation of the
D2/D4-PDGFR-NMDAR Signaling Pathway
D2/D4 dopamine receptors transactivate
PDGFRs via a G pathway in CA1 pyramidal
neurons. The mechanism of this transactiva-
tion is unknown but may also involve PLC
and intracellular Ca2. Once activated,
PDGFRs then induce the release of IP3R-
mediated intracellular Ca2, via a PLCmech-
anism, to enhance Ca2-dependent inactiva-
tion of NMDARs.
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events was minimized by the cut through CA3 made in all slices.transmission. Furthermore, D2/D4 receptors are impli-
Quinpirole was applied following 10 min of stable baseline periodcated in a number of neurological disorders that affect
and epscs were recorded for the following 30 min. Current tracescognition and attention, such as those seen in schizo-
were recorded using a MultiClamp 700A amplifier (Axon Instru-
phrenia and attention deficit hyperactivity disorder ments), low-pass filtered at 2 kHz, and digitized at 10–20 kHz with
(Weinberger, 1999). Glutamatergic hypofunction is also Clampex (version 8, Axon Instruments).
associated with these disorders (Jentsch and Roth,
1999). Indeed, animals expressing reduced levels of the Immunocytochemistry
Procedures for labeling acutely isolated CA1 pyramidal neuronsNMDA receptor display behaviors reminiscent of those
were similar to those previously described (Kotecha et al., 1997).seen in various animal models of schizophrenia (Mohn et
Briefly, CA1 hippocampal neurons were isolated using the proce-al., 1999). As such, the present results provide a possible
dure described previously, with the exception of being isolated onto
cellular mechanism accounting for how D2/D4 receptors coverslips coated with poly-D-lysine (0.5 mg/ml) or collagen (0.5
act via modulation of NMDARs to modulate attention mg/ml). To ensure that the neurons remained adherent to the cov-
erslip, they were centrifuged for less than 1 min at 500 rpm (Interna-and cognition.
tional Clinical Centrifuge). Cells were then exposed for 1 hr to a
monoclonal anti-PDGFR primary antibody (anti-mouse, Transduc-Experimental Procedures
tion Laboratories, cat#: P16920, 1:200) that recognizes the extracel-
lular domain of PDGFRs. Using this approach, only membraneCell Isolation and Whole-Cell Recordings
PDGFRs were labeled. Labeled cells were then challenged withCA1 neurons were isolated from hippocampal slices from postnatal
either PDGF or quinpirole for at least 20 min. Cells were fixed firstrats (Wistar 10–25 days) using previously described procedures
in 4% paraformaldehyde (15 min) and then in cold methanol (20C)(Wang and MacDonald, 1995). To control for variation in response,
for 20 min before they were washed several times in PBS (3/5 min)recordings from control and treated cells were made on the same
and incubated in donkey serum overnight at 4C. A donkey anti-day, unless otherwise indicated. The extracellular solution consisted
mouse secondary antibody conjugated to FITC (Jackson Researchof 140 mM NaCl, 1.3 mM CaCl2, 5 mM KCl, 25 mM HEPES, 33 mM
Laboratories, cat#: 44880, 1:1500) was next applied for 1.5 hr atglucose, and 0.0005 mM TTX, with pH 7.4 and osmolarity between
room temperature. Cells were washed in blocking agent (1% BSA)320 and 325 mosmol. Recordings were done at room temperature
and then PBS before being mounted onto slides using an anti-(20C–22C). After formation of a whole-cell configuration, the re-
fade kit (Molecular Probes, Oregon) and viewed using a confocalcorded neurons were voltage-clamped at 60 mV and lifted into
microscope (Zeiss LM-410).the stream of solution supplied by a computer-controlled, multi-
barreled perfusion system. To monitor access resistance, a voltage
Western Blotting of Phosphorylated PDGF Receptorsstep of 10 mV was made before each application of NMDA. Re-
HEK293 cells stably expressing PDGF receptors were producedcordings where series resistance varied by more than 10% were
by transfecting cells with the vector pBK-PDGFR using Lipofect-rejected. The intracellular solution contained 140 mM CsF or CsCl2,
amine (Gibco BRL) and selection with G418 (200 g/ml). Clonal11 mM EGTA, 1 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 2 mM TEA,
cell lines overexpressing the PDGF receptor were transiently trans-and 2 mM K2ATP with pH 7.2 and osmolarity between 295 and 300
fected with pcDNA3-haD4.2, containing a HA epitope-tagged dopa-mosmol. Some drugs were included in the patch pipette. Data are
mine D4.2 receptor. After overnight incubation without serum, cellsexpressed as mean  SEM and analyzed using a two-way ANOVA.
were stimulated with either dopamine (1 m) or PDGF-BB (10 ng/
ml) and lysates were prepared as described previously (Domin etHippocampal Slice Preparation and Recording
al., 1996). PDGF. receptors were immunoprecipitated by incubatingTransverse hippocampal slices (300 m thick) were made from 2- to
with 1 g of anti-PDGFR (Santa Cruz Biotechnology, Santa Cruz,3-week-old Wistar rats. Briefly, animals were decapitated following
California) (4 hr at 4C) followed by addition of 20 l of 50% Proteinhalothane anesthesia, and their brains quickly removed and placed
A-Sepharose (Pharmacia) (2 hr at 4C). After washing three timesin cooled, oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid
with lysis buffer, pelleted beads were resuspended in sample buffer(aCSF) containing: 124 mM NaCl, 3 mM KCl, 2.6 mM CaCl2, 1.3 mM
and denatured (95C for 2 min). Immunoprecipitated proteins wereMgCl2, 26 mM NaHCO3, 1.25 mM NaH2PO4, and 10–30 mM glucose,
separated by SDS-PAGE and Western blotting was carried out usingwith the osmolarity adjusted between 320–330 mosmol. Whole-brain
anti-phosphotyrosine (Upstate Biotechnology, Lake Placid, Newcoronal slices containing transverse sections of the hippocampus
York) (1 g/ml)/anti-mouse-HRP (Sigma) (1:8000). Western blottingwere prepared using a vibratome (VT100E, Leica). After a recovery
was also carried out on cell lysates using anti-PDGFR (1:500) andperiod of 1 hr in oxygenated aCSF, slices were transferred to a
anti-rabbit-HRP (1:2000; Santa Cruz Biotechnology).recording chamber mounted on the stage of an upright microscope
(BX51WI, Olympus) equipped with a water immersion objective
Preparation of Hippocampal Tissue(40, numerical aperture 0.95, working distance 2.0 mm), Nomarski
The CA1 region of rat hippocampal was sliced and then blocked.optics, and differential-interference contrast (IR-DIC) video micros-
The tissue was sonicated (4  5 s) in 200 l solubilization buffercopy. The CA1 region was isolated from CA3 by a surgical cut and
(20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%slices were continuously perfused with oxygenated aCSF (2–4 ml/
Triton X-100, 30 mM sodium pyrophosphate, 1 mM -glycerophos-min) at room temperature (22C–24C). Tight seals (
1 G) were
phate, 1 mM sodium orthovanadate, 40 mM NaF, 5 g/ml aprotinin,formed on the somata of visually identified CA1 pyramidal cells and
2.5 g/ml pepstatin A, 20 g/ml leupeptin, and 1 mM PMSF). Ho-whole-cell voltage-clamp recordings were obtained by rupturing
mogenates were incubated with gentle rocking for 30 min at 4C.the membrane with negative pressure. Recording electrodes with
Samples were microfuged (13,000 rpm for 20 min) and the superna-resistances of 3–6 Mwere constructed from borosilicate glass (1.5
tant retained. Pellets were resuspended in an additional 200 l ofmm diameter, WPI) using a two-stage puller (PP83, Narashige) and
solubilization buffer, sonicated, and incubated with gentle rockingfilled with internal solution of the following composition: 140 mM
for 30 min at 4C. After microfuging, supernatants were combinedCs-gluconate, 10 mM HEPES, 2 mM MgCl2, and 0.5 mM EGTA (pH
and the protein concentration was determined by BCA assay7.2–7.3, osmolarity 300–310 mosmol). Cells were held at 20 mV
(Pierce, Rockford, Illinois).and series resistance was monitored throughout the recording pe-
riod. Only recordings with stable holding current and series resis-
tance maintained below 30 Mwere considered for analysis. Shaffer ERK Activity Assay
The activity of ERK1/2 in solubilized CA1 hippocampal samples wascollateral synapses were stimulated every 20 s with constant current
pulses (50–100 s) delivered through a concentric bipolar platinum determined with the p44/42 MAP Kinase Assay Kit (Cell Signaling
Technology, Beverly, Massachusetts). Samples (200 g protein instimulating electrode (25 m exposed tip) positioned in stratum
radiatum. Evoked epscsNMDA were isolated by the addition of CNQX 200 l solubilization buffer) were incubated with 15 l immobilized
anti-phospho-p44/42 MAPK (Thr202/Tyr204) monoclonal antibody(20 M) and bicuculline (10 M). The occurrence of polysynaptic
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with gentle rocking for 4 hr at 4C. Anti-phospho-MAPK beads were Arnsten, A.F., Murphy, B., and Merchant, K. (2000). The selective
dopamine D4 receptor antagonist, PNU-101387G, prevents stress-microfuged (14,000 rpm for 30 s) and washed twice with 500 l
solubilization buffer and twice with 500 l kinase buffer (20 mM Tris induced cognitive deficits in monkeys. Neuropsychopharmacology
23, 405–410.[pH 7.5], 5 mM -glycerophosphate, 2 mM DTT, 0.1 mM sodium
orthovanadate, and 10 mM MgCl2). The beads were resuspended Barkley, R.A. (1998). Attention-deficit hyperactivity disorder. Sci.
in 50 l kinase buffer containing 200 M ATP and 2 g GST-Elk-1 Am. 279, 66–71.
fusion protein. Kinase assays were carried out for 30 min at 30C
Blank, T., Nijholt, I., Teichert, U., Kugler, H., Behrsing, H., Fienberg,and stopped by addition of 25 l 3 SDS sample buffer (188 mM
A., Greengard, P., and Spiess, J. (1997). The phosphoproteinTris [pH 6.8], 6% w/v SDS, 30% glycerol, 150 mM DTT, and 0.3%
DARPP-32 mediates cAMP-dependent potentiation of striatalbromophenol blue). Samples were boiled for 5 min, vortexed, and
N-methyl-D-aspartate responses. Proc. Natl. Acad. Sci. USA 94,microfuged for 5 min.
14859–14864.
Bliss, T.V.P., and Collingridge, G.L. (1993). A synaptic model ofSDS-PAGE/Western Blotting of Hippocampal Tissue
memory: long-term potentiation in the hippocampus. Nature 361,Samples (20 l) were separated by SDS-PAGE on an 8%–16% Tris-
31–39.glycine gel (Novex) and transferred to PVDF membrane. After
blocking for 1 hr in blocking buffer (5% w/v nonfat dry milk power Calabresi, P., Saiardi, A., Pisani, A., Baik, J.H., Centonze, D., Mercuri,
in TBS-T [20 mM Tris (pH 7.6), 150 mM NaCl, 0.1% Tween-20]), N.B., Bernardi, G., and Borrelli, E. (1997). Abnormal synaptic plastic-
membranes were incubated with primary antibody (1:1000 anti- ity in the striatum of mice lacking dopamine D2 receptors. J. Neu-
phospho-Elk-1 in blocking buffer) overnight at 4C. Membranes were rosci. 17, 4536–4544.
washed with TBS-T (4  5 min) and incubated with secondary anti- Castro, N.G., de Mello, M.C., de Mello, F.G., and Aracava, Y. (1999).
body (1:2000 anti-rabbit-HRP) for 1 hr at room temperature. Mem- Direct inhibition of the N-methyl-D-aspartate receptor channel by
branes were washed (4  5 min) and detection carried out with dopamine and ()-SKF38393. Br. J. Pharmacol. 126, 1847–1855.
ECL (Amersham Biosciences, New Jersey).
Claesson-Welsh, L. (1994). Platelet-derived growth factor receptor
signals. J. Biol. Chem. 269, 32023–32026.Total ERK Western Blotting
Daub, H., Weiss, F.U., Wallasch, C., and Ullrich, A. (1996). RoleWestern blotting was carried out on solubilized brain samples (8 g
of transactivation of the EGF receptor in signalling by G-protein-protein in SDS sample buffer) as described above using 1:1000 total
coupled receptors. Nature 379, 557–560.p44/42 MAPK antibody (Cell Signaling Technology) and 1:2000 anti-
rabbit-HRP (Cell Signaling Technology). Defagot, M.C., Falzone, T.L., Low, M.J., Grandy, D.K., Rubinstein,
M., and Antonelli, M.C. (2000). Quantitative analysis of the dopamine
Immunoprecipitation and Western Blotting D4 receptor in the mouse brain. J. Neurosci. Res. 59, 202–208.
of Phospho-PDGF Receptor- Della, R.G., Maudsley, S., Daaka, Y., Lefkowitz, R.J., and Luttrell,
Solubilized CA1 hippocampal samples (500 g in 500 l) were incu- L.M. (1999). Pleiotropic coupling of G protein-coupled receptors to
bated with 4 g anti-phosphotyrosine antibody (clone 4G10) (Up- the mitogen-activated protein kinase cascade. Role of focal adhe-
state Biotechnology) with gentle rocking overnight at 4C. Protein- sions and receptor tyrosine kinases. J. Biol. Chem. 274, 13978–
A sepahrose (20 l of a 50% slurry) (Amersham Biosciences) was 13984.
added and samples incubated another 2 hr at 4C. Bead-antibody
Descarries, L., Lemay, B., Doucet, G., and Berger, B. (1987). Regionalcomplexes were washed three times with solubilization buffer and
and laminar density of the dopamine innervation in adult rat cerebralresuspended in 30 l solubilization buffer and 15 l 3 SDS sample
cortex. Neuroscience 21, 807–824.buffer. Samples were boiled 5 min, vortexed, and microfuged 5 min.
Samples (20 l) were separated using 4%–12% Tris-glycine gels Ehlers, M.D., Zhang, S., Bernhadt, J.P., and Huganir, R.L. (1996).
Inactivation of NMDA receptors by direct interaction of calmodulinand transferred to PVDF membrane. Western blotting was carried
out as described above using 1:50 anti-PDGFR (BD Biosciences) with the NR1 subunit. Cell 84, 745–755.
and 1:4000 anti-mouse-HRP (Sigma). Gafni, J., Munsch, J.A., Lam, T.H., Catlin, M.C., Costa, L.G., Molinski,
T.F., and Pessah, I.N. (1997). Xestospongins: potent membrane per-
Total PDGF Receptor- meable blockers of the inositol 1,4,5- trisphosphate receptor. Neu-
Western blotting was carried out on solubilized CA1 hippocampal ron 19, 723–733.
slices (20 g protein in SDS sample buffer) as described above
Gasbarri, A., Verney, C., Innocenzi, R., Campana, E., and Pacitti, C.
using 1:500 total anti-PDGFR (sc-432) (Santa Cruz) and 1:2000
(1994). Mesolimbic dopaminergic neurons innervating the hippo-
anti-rabbit-HRP (Cell Signaling Technology).
campal formation in the rat: a combined retrograde tracing and
immunohistochemical study. Brain Res. 668, 71–79.
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